Prof Steven Lipkin speaks to ecancer at the 2019 American Association for Cancer Research (AACR) meeting about a study looking at the use of a cancer preventative vaccine to treat Lynch syndrome.
He explains that, in order to try and combat the disease earlier and prevent cancer, a vaccine approach was deduced.
Prof Lipkin reports that as few as four recurrent mutations were able to prevent cancer in mice with Lynch syndrome.
He reveals that a phase Ib trial has been proposed to study the use of a vaccine in Lynch syndrome patients.
Read more about this research here.